enhanced risk of very low blood sugar (hypoglycemia) in patients with type two diabetes, In particular people that also choose medicines for type two diabetes for instance sulfonylureas or insulin. This may be both of those a significant and customary side effect. Discuss with your healthcare supplier about how to acknowledge and address low blood